CN104126609B - For cleaning colpomicroscopic thimerosal and preparation method thereof - Google Patents
For cleaning colpomicroscopic thimerosal and preparation method thereof Download PDFInfo
- Publication number
- CN104126609B CN104126609B CN201410411179.XA CN201410411179A CN104126609B CN 104126609 B CN104126609 B CN 104126609B CN 201410411179 A CN201410411179 A CN 201410411179A CN 104126609 B CN104126609 B CN 104126609B
- Authority
- CN
- China
- Prior art keywords
- disinfectant
- acid
- cleaning
- colposcope
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004140 cleaning Methods 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 title 1
- 229940033663 thimerosal Drugs 0.000 title 1
- 239000000645 desinfectant Substances 0.000 claims abstract description 79
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 67
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims abstract description 54
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 27
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 claims abstract description 19
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229950009390 symclosene Drugs 0.000 claims abstract description 17
- 239000000243 solution Substances 0.000 claims description 42
- 239000007853 buffer solution Substances 0.000 claims description 26
- 229960003742 phenol Drugs 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 11
- 239000012982 microporous membrane Substances 0.000 claims description 10
- 239000011148 porous material Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims 1
- 230000000249 desinfective effect Effects 0.000 abstract description 15
- 238000000034 method Methods 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000002425 crystallisation Methods 0.000 abstract description 2
- 230000008025 crystallization Effects 0.000 abstract description 2
- 238000001556 precipitation Methods 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 238000002573 colposcopy Methods 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000004392 genitalia Anatomy 0.000 description 6
- 238000001631 haemodialysis Methods 0.000 description 6
- 230000000322 hemodialysis Effects 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 230000002147 killing effect Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000013112 stability test Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- ISAOUZVKYLHALD-UHFFFAOYSA-N 1-chloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)NC(=O)NC1=O ISAOUZVKYLHALD-UHFFFAOYSA-N 0.000 description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000191940 Staphylococcus Species 0.000 description 5
- 210000003679 cervix uteri Anatomy 0.000 description 5
- -1 polyhexamethylene guanidine Polymers 0.000 description 5
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 206010061978 Genital lesion Diseases 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229960003540 oxyquinoline Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 108091005508 Acid proteases Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000709721 Hepatovirus A Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241001263038 Viguiera Species 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Apparatus For Disinfection Or Sterilisation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明公开了一种用于清洗阴道镜的消毒液,以重量组分计,过氧乙酸0.5%‑1.0%,过氧化氢2.0%‑5.0%,盐酸洗必泰0.1%‑0.5%,苯酚0.01%‑0.05%,水杨酸1.0%‑5.0%,三氯异氰尿酸2.0%‑6.0%,余量为水。本发明研制的阴道镜清洗和消毒液外观无色透明、理化指标性能稳定,在使用期间未见结晶、浑浊、沉淀,各项理化指标表现稳定。与现有技术相比本发明制备消毒剂生产成本低、制备工艺简单、工艺条件易于实现,产品稳定性好。The invention discloses a disinfectant solution for cleaning colposcopes. In terms of components by weight, peracetic acid is 0.5%-1.0%, hydrogen peroxide is 2.0%-5.0%, chlorhexidine hydrochloride is 0.1%-0.5%, and phenol 0.01%‑0.05%, salicylic acid 1.0%‑5.0%, trichloroisocyanuric acid 2.0%‑6.0%, and the balance is water. The colposcope cleaning and disinfecting solution developed by the invention has a colorless and transparent appearance, stable physical and chemical indicators, no crystallization, turbidity, and precipitation during use, and stable performance of various physical and chemical indicators. Compared with the prior art, the production cost of the disinfectant prepared by the invention is low, the preparation process is simple, the process conditions are easy to realize, and the product stability is good.
Description
技术领域technical field
本发明涉及一种消毒液,具体的涉及一种用于清洗阴道镜的消毒液及其制备方法。The invention relates to a disinfectant, in particular to a disinfectant for cleaning colposcopes and a preparation method thereof.
背景技术Background technique
阴道镜(colposcope)是妇科内窥镜之一,也是男女性疾病早期诊断的重要方式,适用于各种宫颈疾病及生殖器病变的诊断,它能将观测到的图像放大10~60倍,发现肉眼不能发现的微小病变。借着这种放大效果,医生可以清楚地看到子宫颈表皮和生殖器表皮上极其微小的病灶细节,有助于提高判断宫颈、生殖器等病变的准确率,为疾病的早期诊断提供依据,使患者提前得到有效的治疗,使疾病的治愈率大大提高。在进行阴道镜检查时,只需用窥阴器暴露阴道、宫颈和生殖器,在距离阴道口或生殖器约20厘米处,将阴道镜镜头对准宫颈或生殖器上表皮组织,调好焦距,通过电脑屏幕观察放大的宫颈图像或生殖器上表皮图像。电脑可以储存和回放这些图像,便于随访观察治疗效果。在检查过程中,病人无痛苦。因此,阴道镜已广泛应用于阴道、宫颈疾病、生殖器病变的检查,被誉为医生的“火眼金睛”。从而深受广大患者及医生的喜爱,广泛使用。Colposcope is one of gynecological endoscopes and an important method for early diagnosis of male and female diseases. It is suitable for the diagnosis of various cervical diseases and genital lesions. Minor lesions that cannot be detected. With this magnification effect, doctors can clearly see the extremely small details of lesions on the epidermis of the cervix and genitals, which helps to improve the accuracy of judging lesions of the cervix and genitals, and provides a basis for early diagnosis of the disease. Get effective treatment in advance, so that the cure rate of the disease is greatly improved. When performing colposcopy, you only need to use a speculum to expose the vagina, cervix and genitals. At a distance of about 20 cm from the vaginal opening or genitals, align the lens of the colposcope with the upper epidermal tissue of the cervix or genitals. A magnified image of the cervix or epidermis of the genitals is viewed on the screen. The computer can store and playback these images, which is convenient for follow-up observation of treatment effect. During the examination, the patient is painless. Therefore, colposcopy has been widely used in the examination of vaginal and cervical diseases and genital lesions, and is known as the "golden eye" of doctors. Thus deeply loved by the majority of patients and doctors, widely used.
阴道镜分类:1.按功能分类:(1)诊断型阴道镜又称标准型阴道镜:该阴道镜仅适用于作检查,而无特殊能源匹配供阴道镜下手术。(2)诊断治疗型阴道镜:该型阴道镜则是将普通型阴道镜和特殊能源相结合,如激光联合型阴道镜等,该阴道镜可以在作阴道镜检查的同时配以同轴激光作局部的激光手术。2.按成像系统分类:(1)光学阴道镜:即指通过光学透镜系统成像的阴道镜。(2)电子阴道镜:即指通过CCD将光学信息转变为数字信息成像的阴道镜。3.按资料储存方式分类:(1)普通型阴道镜:即指阴道镜附件中不含有计算机部分,阴道镜检查资料仍以传统的手写方式保存。图像采集以照相和摄录像为主。(2)计算机化阴道镜:即指光学或电子阴道镜附件中包含有计算机图文信息管理系统部分,阴道镜资料以标准的计算机化语言和实时图像采集并存的方式储存于计算机中。4.按机械分类:阴道镜分为两大系列,分别是电子阴道镜和光电一体阴道镜。电子阴道镜是最先使用的一种,利用数码电子影像技术通过阴道镜成像系统来诊断宫颈疾病;光电一体阴道镜集显微镜光学系统和电子阴道镜成像系统优点于一体而设计的新一代应用于宫颈病变临床诊断的先进设备。Colposcope classification: 1. Classified by function: (1) Diagnostic colposcope, also known as standard colposcope: This colposcope is only suitable for inspection, and there is no special energy matching for colposcopy surgery. (2) Diagnosis and treatment colposcope: This type of colposcope is a combination of ordinary colposcope and special energy, such as laser combined colposcope, etc. This colposcope can be equipped with a coaxial laser while performing colposcopy. For local laser surgery. 2. Classification by imaging system: (1) Optical colposcope: refers to a colposcope that images through an optical lens system. (2) Electronic colposcope: refers to a colposcope that converts optical information into digital information imaging through CCD. 3. Classified by data storage method: (1) Ordinary colposcope: refers to colposcope accessories that do not contain a computer part, and colposcopy examination data are still stored in traditional handwriting. Image acquisition is mainly based on photography and video recording. (2) Computerized colposcope: refers to the optical or electronic colposcope accessories that include a computer graphic information management system. The colposcope data is stored in the computer in a standard computerized language and real-time image acquisition. 4. According to mechanical classification: colposcope is divided into two series, namely electronic colposcope and photoelectric colposcope. Electronic colposcopy is the first to use, using digital electronic imaging technology to diagnose cervical diseases through the colposcope imaging system; the photoelectric integrated colposcope integrates the advantages of microscope optical system and electronic colposcope imaging system and is designed for a new generation of applications Advanced equipment for clinical diagnosis of cervical lesions.
阴道镜结构:1.光学阴道镜 光学阴道镜主要有镜体、支架、光源和附件四大部分组成。(1)镜体:位于支架的顶部,设有倾斜度调节和左右调节手柄,保证镜体可自由地转动。前方有两个物镜,光源出口及滤色镜片。后端有双目目镜,双目镜间距调节以检查者瞳孔间距为准,使双侧目镜的图像重叠,成一最佳的立体图像。(2)支架:分陆地式和悬挂式两种。支架的选择主要取决于阴道镜诊室的条件。(3)光源:有镜内光源和镜外冷光源两种。(4)附件:包括照相系统(普通照相、立体照相和一次成像系统)、摄录像系统、打印系统和计算机图文信息管理系统等。2.电子阴道镜:电子阴道镜包括摄像部分、处理机部分、光源部分、支架部分以及软件部分。光电一体阴道镜包括冷光源部分、光学部分、处理机部分以及软件部分。Colposcope structure: 1. Optical colposcope Optical colposcope mainly consists of four parts: mirror body, bracket, light source and accessories. (1) Mirror body: Located on the top of the bracket, it is equipped with tilt adjustment and left and right adjustment handles to ensure that the mirror body can rotate freely. There are two objective lenses in front, light source outlet and color filter lens. There are binocular eyepieces at the rear end, and the distance between the binoculars is adjusted based on the interpupillary distance of the examiner, so that the images of the two eyepieces overlap to form an optimal stereoscopic image. (2) Bracket: There are two types: land type and suspension type. The choice of stent mainly depends on the conditions of the colposcopy clinic. (3) Light source: There are two kinds of light source inside the mirror and cold light source outside the mirror. (4) Accessories: including camera system (ordinary camera, stereo camera and primary imaging system), video recording system, printing system and computer graphic information management system, etc. 2. Electronic colposcope: Electronic colposcope includes camera part, processor part, light source part, bracket part and software part. The photoelectric integrated colposcope includes a cold light source part, an optical part, a processor part and a software part.
目前,现有专利中很少有专门清洗阴道镜的消毒液,公开号101720760A(申请号200810157978.3)的专利公开了一种血液透析机多功能消毒液,其以过氧乙酸和过氧化氢为主要原料,添加稳定剂水杨酸、EDTA二钠盐、8-羟基喹啉混合而成,具体组成重量百分比为:过氧乙酸4.0%-6.0%,过氧化氢18.0%-22.0%,水杨酸0.3%-1.5%,EDTA二钠盐0.3%-1.0%,8-羟基喹啉0.3%-1.0%,余量为水。公开号103766377A(申请号201210416140.8)的专利公开了一种应用在透析机及水处理的柠檬酸脱钙消毒液及其制备方法,该消毒液包括聚六亚甲基胍、柠檬酸、乳酸、苹果酸,余量为去离子水。所述消毒液的组分配比是聚六亚甲基胍0.001-5.0%、柠檬酸10-50%、乳酸20.0% -40%、苹果酸10%~ 30%、余量为去离子水。本消毒液是由柠檬酸、聚六亚甲基胍、乳酸和苹果酸为主要原料配制而成。公开号101664043(申请号200910307991.7)的专利公开了一种用于消毒、清洗血液透析机水路的消毒液及其制备方法,由柠檬酸、酸性调节剂、酸性蛋白酶、高纯水和过氧化氢制成;其中酸性调节剂在消毒、清洗血液透析机水路消毒液中的质量浓度为2%-5%、酸性蛋白酶在消毒、清洗血液透析机水路消毒液中的质量浓度为3000-6000 SAPU/100ml、过氧化氢在消毒、清洗血液透析机水路消毒液中的质量浓度为8%-10%,柠檬酸在消毒、清洗血液透析机水路消毒液中的质量浓度为40%-50%。At present, there are few disinfectant solutions for cleaning colposcopes in the existing patents. The patent with publication number 101720760A (application number 200810157978.3) discloses a multifunctional disinfectant solution for hemodialysis machines, which mainly uses peracetic acid and hydrogen peroxide. The raw materials are mixed by adding stabilizer salicylic acid, EDTA disodium salt, and 8-hydroxyquinoline. The specific composition weight percentage is: peracetic acid 4.0%-6.0%, hydrogen peroxide 18.0%-22.0%, salicylic acid 0.3%-1.5%, EDTA disodium salt 0.3%-1.0%, 8-hydroxyquinoline 0.3%-1.0%, the balance is water. Publication No. 103766377A (Application No. 201210416140.8) discloses a citric acid decalcification disinfectant used in dialysis machines and water treatment and its preparation method. The disinfectant includes polyhexamethylene guanidine, citric acid, lactic acid, apple acid, and the balance is deionized water. The composition ratio of the disinfectant is 0.001-5.0% of polyhexamethyleneguanidine, 10-50% of citric acid, 20.0%-40% of lactic acid, 10%-30% of malic acid, and the balance is deionized water. This disinfectant is prepared from citric acid, polyhexamethylene guanidine, lactic acid and malic acid as main raw materials. Publication No. 101664043 (Application No. 200910307991.7) discloses a disinfectant for disinfecting and cleaning the waterways of hemodialysis machines and its preparation method, which is made of citric acid, acid regulator, acid protease, high-purity water and hydrogen peroxide; Among them, the mass concentration of the acid regulator in the disinfectant for disinfecting and cleaning the waterway of the hemodialysis machine is 2%-5%, and the mass concentration of the acidic protease in the disinfectant for disinfecting and cleaning the waterway of the hemodialysis machine is 3000-6000 SAPU/100ml. The mass concentration of hydrogen oxide in the disinfectant solution for disinfecting and cleaning the waterway of hemodialysis machines is 8%-10%, and the mass concentration of citric acid in the disinfectant solution for disinfecting and cleaning the waterway of hemodialysis machines is 40%-50%.
由此可见,消毒液在清洗医疗设备方面,有很好的杀菌效果,但是包括上述专利文献在内的现有技术还存在一些不足,首先,现有的相关技术还比较少,而且没有的门用于清洗阴道镜机的消毒液。It can be seen that the disinfectant has a good bactericidal effect in cleaning medical equipment, but there are still some deficiencies in the prior art including the above-mentioned patent documents. First of all, the existing related technologies are relatively few, and there is no door Disinfectant solution for cleaning colposcope machines.
发明内容Contents of the invention
本发明要解决的技术问题是克服现有技术中阴道镜机清洗和消毒液稳定性差的缺点,本发明的目的之一在于提供一种配方合理、性能稳定、使用方便,安全、无毒的稳定性较好的用于阴道镜机清洗和消毒的消毒液。另一目的就是提供上述消毒液的制备方法。The technical problem to be solved by the present invention is to overcome the shortcomings of poor stability of colposcope machine cleaning and disinfectant in the prior art. One of the purposes of the present invention is to provide a stable, safe, non-toxic and stable It is a disinfectant solution for cleaning and disinfecting colposcope machines with better performance. Another object is exactly to provide the preparation method of above-mentioned disinfectant.
本发明的上述目的是通过以下技术方案来实现的:Above-mentioned purpose of the present invention is achieved through the following technical solutions:
用于清洗阴道镜的消毒液,以重量组分计,过氧乙酸0.5%-1.0%,过氧化氢2.0%-5.0%,盐酸洗必泰0.1%-0.5%,苯酚0.01%-0.05%,水杨酸1.0%-5.0%(优选的,水杨酸1.2%-4.5%;更加优选的,水杨酸3.5%),三氯异氰尿酸2.0%-6.0%,余量为水。Disinfectants for cleaning colposcopes, by weight components, peracetic acid 0.5%-1.0%, hydrogen peroxide 2.0%-5.0%, chlorhexidine hydrochloride 0.1%-0.5%, phenol 0.01%-0.05%, Salicylic acid 1.0%-5.0% (preferably, salicylic acid 1.2%-4.5%; more preferably, salicylic acid 3.5%), trichloroisocyanuric acid 2.0%-6.0%, and the balance is water.
根据前面所述的用于清洗阴道镜的消毒液,优选的方案在于:以重量组分计:过氧乙酸0.6%-0.9%,过氧化氢2.5%-4.5%,盐酸洗必泰0.2%-0.4%,苯酚0.02%-0.04%,水杨酸2.0%-4.0%,三氯异氰尿酸3.0%-5.0%,余量为水。According to the aforementioned disinfectant solution for cleaning colposcopes, the preferred scheme is: in terms of weight components: peracetic acid 0.6%-0.9%, hydrogen peroxide 2.5%-4.5%, chlorhexidine hydrochloride 0.2%- 0.4%, phenol 0.02%-0.04%, salicylic acid 2.0%-4.0%, trichloroisocyanuric acid 3.0%-5.0%, and the balance is water.
根据前面所述的用于清洗阴道镜的消毒液,更佳优选的方案在于,以重量组分计,过氧乙酸0.8%,过氧化氢3.0%,盐酸洗必泰0.3%,苯酚0.03%,水杨酸3.0%,三氯异氰尿酸4.0%,余量为水。According to the aforementioned disinfectant solution for cleaning colposcopes, the more preferred solution is, in terms of weight components, peracetic acid 0.8%, hydrogen peroxide 3.0%, chlorhexidine hydrochloride 0.3%, phenol 0.03%, Salicylic acid 3.0%, trichloroisocyanuric acid 4.0%, and the balance is water.
根据前面任一项所述的用于清洗阴道镜的消毒液的制备方法,包括以下步骤:According to any one of the preparation methods for cleaning colposcope disinfectant, comprising the following steps:
(1)将盐酸洗必泰、苯酚和水杨酸加入配液罐中,2-6分钟后加入三氯异氰尿酸,静置1-3小时后加入水,在40-60℃下搅拌0.5-1.5小时后得缓冲溶液,然后将缓冲溶液温度降至-5-0℃;(1) Add chlorhexidine hydrochloride, phenol and salicylic acid into the liquid preparation tank, add trichloroisocyanuric acid after 2-6 minutes, add water after standing for 1-3 hours, stir at 40-60°C for 0.5 After -1.5 hours, the buffer solution was obtained, and then the temperature of the buffer solution was lowered to -5-0°C;
(2)将过氧化氢和过氧乙酸滴加到步骤(1)所得缓冲溶液中,继续搅拌0.5-1小时得消毒液;(2) Add hydrogen peroxide and peracetic acid dropwise to the buffer solution obtained in step (1), and continue stirring for 0.5-1 hour to obtain a disinfectant;
(3)将步骤(2)所得消毒液通过微孔滤膜过滤,分装即得。(3) Filter the disinfectant solution obtained in step (2) through a microporous membrane, and pack it separately.
根据前面所述的制备方法,优选的方案在于:步骤(1)3-5分钟后加入三氯异氰尿酸,静置1.5-2.5小时后加入水(优选4分钟后加入三氯异氰尿酸,静置2小时后加入水)。According to the above-mentioned preparation method, the preferred solution is: step (1) add trichloroisocyanuric acid after 3-5 minutes, add water after standing for 1.5-2.5 hours (preferably add trichloroisocyanuric acid after 4 minutes, Add water after standing for 2 hours).
根据前面所述的制备方法,优选的方案在于:步骤(1)在45-55℃下搅拌0.6-0.8小时后得缓冲溶液(优选在50℃下搅拌1小时后得缓冲溶液)。According to the above-mentioned preparation method, the preferred solution is: step (1) obtain a buffer solution after stirring at 45-55° C. for 0.6-0.8 hours (preferably obtain a buffer solution after stirring at 50° C. for 1 hour).
根据前面所述的制备方法,优选的方案在于:步骤(1)将缓冲溶液温度降至-4到-2℃(优选的将缓冲溶液温度降至-3℃)。According to the aforementioned preparation method, the preferred solution is: step (1) lowering the temperature of the buffer solution to -4 to -2°C (preferably lowering the temperature of the buffer solution to -3°C).
根据前面所述的制备方法,优选的方案在于:步骤(2)继续搅拌0.5-0.8小时得消毒液(优选的继续搅拌0.6小时得消毒液)。According to the above-mentioned preparation method, the preferred solution is: step (2) continue to stir for 0.5-0.8 hours to obtain a disinfectant solution (preferably continue to stir for 0.6 hours to obtain a disinfectant solution).
根据前面所述的制备方法,优选的方案在于:步骤(3)所述微孔滤膜的孔径为0.10-0.45μm(优选孔径为0.22μm)。According to the aforementioned preparation method, the preferred solution is: the pore diameter of the microporous membrane in step (3) is 0.10-0.45 μm (preferably 0.22 μm).
根据前面任一所述的用于清洗阴道镜的消毒液在制备用于阴道镜机、B超仪、CT机的消毒液时的应用。According to the application of the disinfectant solution for cleaning colposcope according to any one of the foregoing when preparing the disinfectant solution for colposcope machine, B-ultrasonic instrument, and CT machine.
各原料的介绍如下:The introduction of each raw material is as follows:
过氧乙酸:是无色液体,具有乙酸的典型气味。过氧乙酸是强氧化剂。医药工业用作饮水、食品和防止传染病的消毒剂。过氧乙酸为强氧化剂,有很强的氧化性,遇有机物放出新生态氧而起氧化作用,与次氯酸钠(又名84消毒液)、漂白粉等被作为医疗或生活消毒药物使用,为高效、速效、低毒、广谱杀菌剂,对细菌繁殖体、芽孢、病毒、霉菌均有杀灭作用。因此可用它来进行杀菌、消毒。此外,由于过氧乙酸在空气中具有较强的挥发性,对空气进行杀菌、消毒具有良好的效果,而且价格便宜,目前我们在预防非典时的杀菌、消毒剂主要就是过氧乙酸。Peracetic Acid: It is a colorless liquid with the typical odor of acetic acid. Peracetic acid is a strong oxidizing agent. In the pharmaceutical industry, it is used as a disinfectant for drinking water, food and preventing infectious diseases. Peracetic acid is a strong oxidizing agent and has strong oxidizing properties. When it encounters organic matter, it releases new ecological oxygen to oxidize. It is used as a medical or life disinfection drug together with sodium hypochlorite (also known as 84 disinfectant) and bleaching powder. It is highly effective and quick-acting. , low toxicity, broad-spectrum fungicide, has killing effect on bacterial propagules, spores, viruses and molds. Therefore, it can be used for sterilization and disinfection. In addition, because peracetic acid has strong volatility in the air, it has a good effect on sterilization and disinfection of the air, and it is cheap. At present, the main sterilization and disinfectant we use to prevent SARS is peracetic acid.
过氧化氢:俗称双氧水,有微弱的特殊气味,可用作消毒剂。纯过氧化氢是淡蓝色的油状液体。能与水、乙醇或乙醚以任何比例混合。双氧水是无色有刺激性气味的液体。医疗上常用3%的双氧水进行伤口或中耳炎消毒。当它与皮肤、口腔和黏膜的伤口、脓液或污物相遇时,立即分解生成氧。这种尚未结合成氧分子的氧原子,具有很强的氧化能力,与细菌接触时,能破坏细菌菌体,杀死细菌。杀灭细菌后剩余的物质是无任何毒害、无任何刺激作用的水。不会形成二次污染。因此,双氧水是伤口消毒理想的消毒剂。但需要注意的是,不能用浓度大的双氧水进行伤口消毒,以防灼伤皮肤及患处。Hydrogen peroxide: Commonly known as hydrogen peroxide, it has a faint special smell and can be used as a disinfectant. Pure hydrogen peroxide is a light blue oily liquid. Can be mixed with water, ethanol or ether in any proportion. Hydrogen peroxide is a colorless liquid with a pungent odor. Medically, 3% hydrogen peroxide is commonly used to disinfect wounds or otitis media. When it meets wounds, pus or dirt on the skin, oral cavity and mucous membranes, it immediately decomposes to generate oxygen. This oxygen atom, which has not yet been combined into oxygen molecules, has a strong oxidizing ability. When it comes into contact with bacteria, it can destroy the bacterial cells and kill the bacteria. The remaining substance after killing the bacteria is water without any poison or irritation. No secondary pollution will be formed. Therefore, hydrogen peroxide is an ideal disinfectant for wound disinfection. However, it should be noted that high-concentration hydrogen peroxide cannot be used for wound disinfection to prevent burns to the skin and affected areas.
盐酸洗必泰:盐酸洗必泰为消毒防腐剂,其抑菌杀菌作用广而强,对革兰氏阳性茵比阴性茵的抗茵作用强,比季铵盐类阳离子表面活性剂为强,对真菌也有效,但对耐酸菌、芽胞和病毒无效。在有血清、血液存在时仍然有效。对组织无刺激性,为白色或几乎白色结晶性粉末;无臭,味苦。极微溶于水,微溶于乙醇,略溶于丙二醇。Chlorhexidine hydrochloride: Chlorhexidine hydrochloride is a disinfectant and preservative. Its antibacterial and bactericidal effects are broad and strong. It has a stronger antibacterial effect on Gram-positive bacteria than negative bacteria, and is stronger than quaternary ammonium cationic surfactants. It is also effective against fungi, but not against acid-fast bacteria, spores and viruses. It is still effective in the presence of serum and blood. Non-irritating to tissues, white or almost white crystalline powder; odorless, bitter taste. Very slightly soluble in water, slightly soluble in ethanol, slightly soluble in propylene glycol.
苯酚:苯酚(Phenol,C6H5OH)是一种具有特殊气味的无色针状晶体,有毒,是生产某些树脂、杀菌剂、防腐剂以及药物(如阿司匹林)的重要原料。也可用于用于消毒外科器械和排泄物的处理,皮肤杀菌、止痒及中耳炎。常温下微溶于水,易溶于有机溶剂;当温度高于65℃时,能跟水以任意比例互溶。苯酚有腐蚀性,接触后会使局部蛋白质变性,其溶液沾到皮肤上可用酒精洗涤。苯酚暴露在空气中被氧气氧化为醌而呈粉红色。Phenol: Phenol (Phenol, C6H5OH) is a colorless needle-shaped crystal with a special odor, which is toxic and is an important raw material for the production of certain resins, fungicides, preservatives and drugs (such as aspirin). It can also be used for disinfection of surgical instruments and treatment of excrement, skin sterilization, antipruritic and otitis media. Slightly soluble in water at room temperature, easily soluble in organic solvents; when the temperature is higher than 65°C, it can be miscible with water in any proportion. Phenol is corrosive and will denature local proteins after contact. Its solution can be washed with alcohol when it touches the skin. Phenol turns pink when exposed to air and is oxidized to quinone by oxygen.
水杨酸:水杨酸是一种脂溶性的有机酸,所以它可以轻松瓦解肌肤表面多余的皮脂,同时抑制皮脂过量分泌,对于因皮脂堵塞形成的角栓、痘痘也有较强的溶解作用,改善毛囊壁不洁净的状态,帮助皮脂从毛孔中顺利排除,同时借由抑菌的特性快速收干痘痘。水杨酸能够溶解细胞和细胞之间用于连接的物质,使老化角质细胞从肌肤表面快速脱落,从而促进肌肤的新陈代谢,恢复肌肤细致的触感。肌肤表层的色素沉积通常发生在不健康的角质细胞层中,使用水杨酸能够帮助剥离这一层老化角质细胞,就像镜子被擦干净之后重新恢复明朗清晰的印象。另外,水杨酸能辅助其他酸类美白成分的渗透,水杨酸常做稳定剂使用。Salicylic acid: Salicylic acid is a fat-soluble organic acid, so it can easily disintegrate excess sebum on the skin surface, and at the same time inhibit excessive sebum secretion. It also has a strong dissolution effect on corner plugs and acne caused by sebum blockage , improve the unclean state of the hair follicle wall, help sebum to be removed from the pores smoothly, and at the same time use the antibacterial properties to quickly dry up acne. Salicylic acid can dissolve cells and the substances used for connection between cells, so that aging keratinocytes can be quickly shed from the skin surface, thereby promoting skin metabolism and restoring the delicate touch of the skin. Pigmentation on the surface of the skin usually occurs in the unhealthy keratinocyte layer. The use of salicylic acid can help peel off this layer of aging keratinocytes, just like a mirror that has been wiped clean to restore a clear and clear impression. In addition, salicylic acid can assist the penetration of other acidic whitening ingredients, and salicylic acid is often used as a stabilizer.
三氯异氰尿酸,有机化合物,白色结晶性粉末或粒状固体,具有强烈的氯气刺激味。三氯异氰尿酸是一种极强的氧化剂和氯化剂,具有高效、广谱、较为安全的消毒作用,对细菌、病毒、真菌、芽孢等都有杀灭作用,对球虫卵囊也有一定杀灭作用。几乎对所有的真菌、细菌、病毒芽孢都有杀灭作用,对杀灭甲肝、乙肝病毒具有特效,对性病毒和艾滋病毒也具有良好的消毒效果,使用安全方便,该产品还可以广泛应用于食品,奶制品,水稻种子处理,水果保鲜、纤维漂白、羊毛防缩,日用化工脱色,木材防霉造纸,橡胶氧化和电池材料等方面。Trichloroisocyanuric acid, an organic compound, white crystalline powder or granular solid, has a strong chlorine gas pungent smell. Trichloroisocyanuric acid is a very strong oxidizing agent and chlorinating agent. It has high-efficiency, broad-spectrum and relatively safe disinfection effect. It has a killing effect on bacteria, viruses, fungi, spores, etc. Definitely killing effect. It has a killing effect on almost all fungi, bacteria, and viral spores. It has special effects on killing hepatitis A and hepatitis B viruses. It also has a good disinfection effect on sexual viruses and HIV. It is safe and convenient to use. This product can also be widely used in Food, dairy products, rice seed treatment, fruit preservation, fiber bleaching, wool anti-shrinkage, daily chemical decolorization, wood anti-mold papermaking, rubber oxidation and battery materials, etc.
本发明研制的阴道镜清洗和消毒液外观无色透明、理化指标性能稳定,在使用期间未见结晶、浑浊、沉淀,各项理化指标表现稳定。与现有技术相比本发明制备消毒剂生产成本低、制备工艺简单、工艺条件易于实现,产品稳定性好。The colposcope cleaning and disinfecting solution developed by the invention has a colorless and transparent appearance, stable physical and chemical indicators, no crystallization, turbidity, and precipitation during use, and stable performance of various physical and chemical indicators. Compared with the prior art, the production cost of the disinfectant prepared by the invention is low, the preparation process is simple, the process conditions are easy to realize, and the product stability is good.
具体实施方式detailed description
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。The technical solutions of the present invention will be described in detail below in conjunction with the examples and experimental examples, but the scope of protection is not limited thereto.
实施例1 一种用于清洗阴道镜的消毒液,以重量组分计:过氧乙酸0.5%,过氧化氢2.0%,盐酸洗必泰0.1%,苯酚0.01%,水杨酸1.0%,三氯异氰尿酸2.0%,余量为水。Example 1 A disinfectant solution for cleaning colposcopes, by weight components: 0.5% peracetic acid, 2.0% hydrogen peroxide, 0.1% chlorhexidine hydrochloride, 0.01% phenol, 1.0% salicylic acid, three Chloroisocyanuric acid 2.0%, the balance is water.
一种用于清洗阴道镜的消毒液的制备步骤如下:A kind of preparation step for the disinfectant solution of cleaning colposcope is as follows:
(1)将盐酸洗必泰、苯酚和水杨酸加入配液罐中,2分钟后加入三氯异氰尿酸,静置1小时后加入水,在40℃下搅拌0.5小时后得缓冲溶液,然后将缓冲溶液温度降至-5℃;(1) Add chlorhexidine hydrochloride, phenol and salicylic acid into the liquid preparation tank, add trichloroisocyanuric acid after 2 minutes, add water after standing for 1 hour, and stir at 40°C for 0.5 hours to obtain a buffer solution, Then lower the temperature of the buffer solution to -5°C;
(2)将过氧化氢和过氧乙酸滴加到步骤(1)所得缓冲溶液中,继续搅拌0.3小时得消毒液;(2) Add hydrogen peroxide and peracetic acid dropwise to the buffer solution obtained in step (1), and continue stirring for 0.3 hours to obtain a disinfectant;
(3)将步骤(2)所得消毒液通过微孔滤膜过滤,分装即得。(3) Filter the disinfectant solution obtained in step (2) through a microporous membrane, and pack it separately.
稳定性试验1:取上述实施例1所得用于阴道镜清洗消毒的消毒液,参考《消毒技术规范》2002版进行稳定性测试,存放条件:在37℃下,检测环境:温度30℃,相对湿度40%-44%。结果如下表1所示:Stability test 1: Take the disinfectant solution obtained in Example 1 above for cleaning and disinfection of colposcopes, and conduct a stability test with reference to the 2002 edition of "Technical Specifications for Disinfection". Storage conditions: at 37°C, testing environment: temperature 30°C Humidity 40%-44%. The results are shown in Table 1 below:
表1Table 1
通过37℃加速试验证明,实施例1所得的用于阴道镜清洗消毒的消毒液的有效成分过氧乙酸和过氧化氢的含量基本没有下降,仅有少量过氧化氢发生分解;表明本发明用于阴道镜清洗消毒的消毒液的稳定性良好,在存储和运输过程中不会发生大量分解。Prove by 37 ℃ of accelerated tests, the active ingredient peracetic acid and the content of hydrogen peroxide of the disinfectant liquid that embodiment 1 gained is used for cleaning and disinfecting colposcope do not descend substantially, and only a small amount of hydrogen peroxide decomposes; Show that the present invention uses The disinfectant used for cleaning and disinfecting colposcopes has good stability and will not undergo a large amount of decomposition during storage and transportation.
实施例2一种用于清洗阴道镜的消毒液,以重量组分计:过氧乙酸1.0%,过氧化氢5.0%,盐酸洗必泰0.5%,苯酚0.05%,水杨酸5.0%,三氯异氰尿酸6.0%,余量为水。Embodiment 2 A kind of disinfectant for cleaning colposcope, by weight components: peracetic acid 1.0%, hydrogen peroxide 5.0%, chlorhexidine hydrochloride 0.5%, phenol 0.05%, salicylic acid 5.0%, three Chloroisocyanuric acid 6.0%, the balance is water.
一种用于清洗阴道镜的消毒液的制备步骤如下:A kind of preparation step for the disinfectant solution of cleaning colposcope is as follows:
(1)将盐酸洗必泰、苯酚和水杨酸加入配液罐中,6分钟后加入三氯异氰尿酸,静置3小时后加入水,在60℃下搅拌1.5小时后得缓冲溶液,然后将缓冲溶液温度降至0℃;(1) Add chlorhexidine hydrochloride, phenol and salicylic acid into the liquid preparation tank, add trichloroisocyanuric acid after 6 minutes, add water after standing for 3 hours, and stir at 60°C for 1.5 hours to obtain a buffer solution. Then lower the temperature of the buffer solution to 0°C;
(2)将过氧化氢和过氧乙酸滴加到步骤(1)所得缓冲溶液中,继续搅拌1小时得消毒液;(2) Add hydrogen peroxide and peracetic acid dropwise to the buffer solution obtained in step (1), and continue stirring for 1 hour to obtain a disinfectant;
(3)将步骤(2)所得消毒液通过微孔滤膜过滤,分装即得。(3) Filter the disinfectant solution obtained in step (2) through a microporous membrane, and pack it separately.
稳定性试验2:取上述实施例2所得用于阴道镜清洗消毒的消毒液,参考《消毒技术规范》2002版进行稳定性测试,存放条件:在37℃放置。检测环境:温度30℃,相对湿度40%-44%。结果如下表2所示:Stability test 2: Take the disinfectant used for cleaning and disinfecting colposcopes obtained in Example 2 above, and conduct a stability test with reference to the 2002 edition of "Technical Specifications for Disinfection". Storage conditions: place at 37°C. Testing environment: temperature 30°C, relative humidity 40%-44%. The results are shown in Table 2 below:
表2Table 2
通过37℃加速试验证明,实施例2所得的用于阴道镜清洗消毒的消毒液的有效成分过氧乙酸和过氧化氢的含量基本没有下降,仅有少量过氧化氢发生分解;表明本发明用于阴道镜清洗消毒的消毒液的稳定性良好,在存储和运输过程中不会发生大量分解。Prove by 37 ℃ of accelerated tests, the content of active ingredient peracetic acid and hydrogen peroxide of the disinfectant liquid that embodiment 2 gained is used for cleaning and disinfecting colposcope does not descend substantially, and only a small amount of hydrogen peroxide decomposes; Show that the present invention uses The disinfectant used for cleaning and disinfecting colposcopes has good stability and will not undergo a large amount of decomposition during storage and transportation.
实施例3一种用于清洗阴道镜的消毒液,以重量组分计:过氧乙酸0.6%,过氧化氢2.5%,盐酸洗必泰0.2%,苯酚0.02%,水杨酸2.0%,三氯异氰尿酸3.0%,余量为水。Example 3 A disinfectant for cleaning colposcopes, in terms of weight components: 0.6% peracetic acid, 2.5% hydrogen peroxide, 0.2% chlorhexidine hydrochloride, 0.02% phenol, 2.0% salicylic acid, three Chloroisocyanuric acid 3.0%, the balance is water.
一种用于清洗阴道镜的消毒液的制备步骤如下:A kind of preparation step for the disinfectant solution of cleaning colposcope is as follows:
(1)将盐酸洗必泰、苯酚和水杨酸加入配液罐中,3分钟后加入三氯异氰尿酸,静置1.5小时后加入水,在45℃下搅拌0.8小时后得缓冲溶液,然后将缓冲溶液温度降至-4℃;(1) Add chlorhexidine hydrochloride, phenol and salicylic acid into the mixing tank, add trichloroisocyanuric acid after 3 minutes, add water after standing for 1.5 hours, and stir at 45°C for 0.8 hours to obtain a buffer solution. Then lower the temperature of the buffer solution to -4°C;
(2)将过氧化氢和过氧乙酸滴加到步骤(1)所得缓冲溶液中,继续搅拌0.5小时得消毒液;(2) Add hydrogen peroxide and peracetic acid dropwise to the buffer solution obtained in step (1), and continue stirring for 0.5 hours to obtain a disinfectant;
(3)将步骤(2)所得消毒液通过微孔滤膜过滤,分装即得。(3) Filter the disinfectant solution obtained in step (2) through a microporous membrane, and pack it separately.
稳定性试验3:取上述实施例3制备的用于阴道镜清洗消毒的消毒液,参考《消毒技术规范》2002版进行稳定性测试,存放条件:在37℃下放置。检测环境:温度30℃,相对湿度40%-44%。结果如下表3所示:Stability test 3: Take the disinfectant solution used for cleaning and disinfecting colposcopes prepared in Example 3 above, and conduct a stability test with reference to the 2002 edition of "Technical Specifications for Disinfection". Storage conditions: place at 37°C. Testing environment: temperature 30°C, relative humidity 40%-44%. The results are shown in Table 3 below:
表3table 3
通过37℃加速试验证明,实施例3所得的用于阴道镜清洗消毒的消毒液的有效成分过氧乙酸和过氧化氢的含量基本没有下降,仅有少量过氧化氢发生分解;表明本发明用于阴道镜清洗消毒的消毒液的稳定性良好,在存储和运输过程中不会发生大量分解。Prove by 37 ℃ of accelerated tests, the content of active ingredient peracetic acid and hydrogen peroxide of the disinfectant liquid that embodiment 3 gained is used for colposcope cleaning and disinfection does not decline substantially, and only a small amount of hydrogen peroxide decomposes; Show that the present invention uses The disinfectant used for cleaning and disinfecting colposcopes has good stability and will not undergo a large amount of decomposition during storage and transportation.
实施例4 一种用于清洗阴道镜的消毒液,以重量组分计:过氧乙酸0.9%,过氧化氢4.5%,盐酸洗必泰0.4%,苯酚0.04%,水杨酸4.0%,三氯异氰尿酸5.0%,余量为水。Example 4 A disinfectant solution for cleaning colposcopes, by weight components: 0.9% peracetic acid, 4.5% hydrogen peroxide, 0.4% chlorhexidine hydrochloride, 0.04% phenol, 4.0% salicylic acid, three Chloroisocyanuric acid 5.0%, the balance is water.
一种用于清洗阴道镜的消毒液的制备步骤如下:A kind of preparation step for the disinfectant solution of cleaning colposcope is as follows:
(1)将盐酸洗必泰、苯酚和水杨酸加入配液罐中,5分钟后加入三氯异氰尿酸,静置2.5小时后加入水,在55℃下搅拌1.3小时后得缓冲溶液,然后将缓冲溶液温度降至-4℃;(1) Add chlorhexidine hydrochloride, phenol and salicylic acid into the liquid preparation tank, add trichloroisocyanuric acid after 5 minutes, add water after standing for 2.5 hours, and stir at 55°C for 1.3 hours to obtain a buffer solution. Then lower the temperature of the buffer solution to -4°C;
(2)将过氧化氢和过氧乙酸滴加到步骤(1)所得缓冲溶液中,继续搅拌0.8小时得消毒液;(2) Add hydrogen peroxide and peracetic acid dropwise to the buffer solution obtained in step (1), and continue stirring for 0.8 hours to obtain a disinfectant;
(3)将步骤(2)所得消毒液通过微孔滤膜过滤,分装即得。(3) Filter the disinfectant solution obtained in step (2) through a microporous membrane, and pack it separately.
实施例5 一种用于清洗阴道镜的消毒液,以重量组分计,过氧乙酸0.8%,过氧化氢3.0%,盐酸洗必泰0.3%,苯酚0.03%,水杨酸3.0%,三氯异氰尿酸4.0%,余量为水。Example 5 A disinfectant for cleaning colposcopes, by weight components, peracetic acid 0.8%, hydrogen peroxide 3.0%, chlorhexidine hydrochloride 0.3%, phenol 0.03%, salicylic acid 3.0%, three Chloroisocyanuric acid 4.0%, the balance is water.
一种用于清洗阴道镜的消毒液的制备步骤如下:A kind of preparation step for the disinfectant solution of cleaning colposcope is as follows:
(1)将盐酸洗必泰、苯酚和水杨酸加入配液罐中,4分钟后加入三氯异氰尿酸,静置2小时后加入水,在50℃下搅拌1小时后得缓冲溶液,然后将缓冲溶液温度降至-3℃;(1) Add chlorhexidine hydrochloride, phenol and salicylic acid into the mixing tank, add trichloroisocyanuric acid after 4 minutes, add water after standing for 2 hours, and stir at 50°C for 1 hour to obtain a buffer solution. Then lower the temperature of the buffer solution to -3°C;
(2)将过氧化氢和过氧乙酸滴加到步骤(1)所得缓冲溶液中,继续搅拌0.7小时得消毒液;(2) Add hydrogen peroxide and peracetic acid dropwise to the buffer solution obtained in step (1), and continue stirring for 0.7 hours to obtain a disinfectant;
(3)将步骤(2)所得消毒液通过微孔滤膜过滤,分装即得。(3) Filter the disinfectant solution obtained in step (2) through a microporous membrane, and pack it separately.
实验例1:对实施例5制备的消毒液以念珠菌、霉菌、葡萄球菌和淋病双球菌对医疗器械的消毒模拟现场试验:Experimental example 1: the disinfectant solution prepared in embodiment 5 is used Candida, mould, Staphylococcus and Neisseria gonorrhoeae to the disinfection simulation field test of medical equipment:
分别取念珠菌悬液、霉菌悬液、葡萄球菌悬液和淋病双球菌悬液滴染于聚四氟乙烯管内部涂布均匀,置于37℃恒温培养箱中干燥,制备染菌载体。以本发明所得的产品为消毒剂,按照阴道镜机使用说明书消毒规程进行清洗消毒,结果如下表4所示:Candida suspension, mold suspension, Staphylococcus suspension and Neisseria gonorrhoeae suspension were drip-stained on the inside of polytetrafluoroethylene tubes, spread evenly, and placed in a 37°C constant temperature incubator to dry to prepare bacteria-contaminated carriers. With the product of the present invention gained as disinfectant, carry out cleaning and disinfection according to colposcope machine instruction manual disinfection procedure, the result is as shown in table 4 below:
表4该消毒液对细菌的杀灭对数值Table 4 This disinfectant kills the logarithmic value of bacteria
结果显示本产品对染于聚四氟乙烯管上的念珠菌、霉菌、葡萄球菌和淋病双球菌的杀灭对数值>5.89,表明本产品具有很好的杀菌消毒效果。The results showed that the logarithmic value of this product against Candida, mold, Staphylococcus and Neisseria gonorrhoeae stained on the polytetrafluoroethylene tube was >5.89, indicating that this product has a good sterilization and disinfection effect.
实验例2:为了验证实施例5所得消毒液的杀菌消毒效果,分别取念珠菌悬液、霉菌悬液、葡萄球菌悬液和淋病双球菌悬液滴染于聚四氟乙烯管内部涂布均匀,置于37℃恒温培养箱中干燥,制备染菌载体。将制备好的染菌载体,分为两组,实验组和对照组,实验组以本发明所得的产品为消毒剂,按照阴道镜机使用说明书消毒规程进行清洗消毒,对照组以其他消毒剂对阴道镜机进行清洗杀菌(例如柠檬酸消毒液、医用碱性低泡清洗剂等常规消毒剂),结果如下表5所示:Experimental Example 2: In order to verify the sterilization and disinfection effect of the disinfectant solution obtained in Example 5, the candida suspension, mold suspension, staphylococcus suspension and gonorrhea suspension were respectively drip-stained on the inside of the polytetrafluoroethylene tube and coated evenly , placed in a constant temperature incubator at 37°C and dried to prepare the bacteria-contaminated carrier. The prepared bacteria-infected carrier is divided into two groups, an experimental group and a control group. The experimental group uses the product obtained in the present invention as a disinfectant, and cleans and disinfects according to the disinfection procedures of the colposcopy machine instruction manual. The control group uses other disinfectants to treat the bacteria. The colposcope machine was cleaned and sterilized (such as conventional disinfectants such as citric acid disinfectant, medical alkaline low-foaming detergent), and the results are shown in Table 5 below:
表5为本发明所得消毒液对细菌的杀灭对数值Table 5 is the kill logarithmic value of the disinfectant solution of the present invention to bacteria
结果:两组杀菌疗效比较,本产品对染于聚四氟乙烯管上的念珠菌、霉菌、葡萄球菌和淋病双球菌的杀灭对数值>5.89,明显杀菌效果比对照组好,表明本产品具有很好的杀菌消毒效果。Results: Compared the bactericidal efficacy of the two groups, the logarithmic value of this product against Candida, mold, Staphylococcus and Neisseria gonorrhoeae stained on the PTFE tube was >5.89, and the bactericidal effect was obviously better than that of the control group, indicating that this product It has good sterilization and disinfection effect.
以上参照本发明的实施例对本发明予以了说明。但是,这些实施例仅是为了说明的目的,而并非为了限制本发明的范围。本发明的范围由所附权利要求及其等价物限定。不脱离本发明的范围,本领域技术人员可以做出多种替换和修改,这些替换和修改都应落在本发明的范围之内。The present invention has been described above with reference to the embodiments of the present invention. However, these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. The scope of the invention is defined by the appended claims and their equivalents. Those skilled in the art can make various substitutions and modifications without departing from the scope of the present invention, and these substitutions and modifications should all fall within the scope of the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410411179.XA CN104126609B (en) | 2014-08-20 | 2014-08-20 | For cleaning colpomicroscopic thimerosal and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410411179.XA CN104126609B (en) | 2014-08-20 | 2014-08-20 | For cleaning colpomicroscopic thimerosal and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104126609A CN104126609A (en) | 2014-11-05 |
CN104126609B true CN104126609B (en) | 2016-08-24 |
Family
ID=51799662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410411179.XA Expired - Fee Related CN104126609B (en) | 2014-08-20 | 2014-08-20 | For cleaning colpomicroscopic thimerosal and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104126609B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104430569A (en) * | 2014-11-25 | 2015-03-25 | 邓建军 | Disinfectant for cleaning CT equipment and preparation method thereof |
CN104782671A (en) * | 2015-03-25 | 2015-07-22 | 彭新国 | Bacteriostatic disinfecting disinfectant for laboratory department and preparation method for bacteriostatic disinfecting disinfectant |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0147207A1 (en) * | 1983-12-22 | 1985-07-03 | Albright & Wilson Limited | Disinfectants |
CN101426539A (en) * | 2006-02-28 | 2009-05-06 | 贝克顿·迪金森公司 | Antimicrobial compositions and methods for locking catheters |
CN101720760A (en) * | 2008-10-17 | 2010-06-09 | 山东威高药业有限公司 | Multifunctional disinfectant for haemodialysis machine |
CN103766377A (en) * | 2012-10-26 | 2014-05-07 | 杭州元祺生物科技有限公司 | Citric acid decalcified disinfectant applied to dialysis machinery and water treatment and preparation method of citric acid decalcified disinfectant |
-
2014
- 2014-08-20 CN CN201410411179.XA patent/CN104126609B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0147207A1 (en) * | 1983-12-22 | 1985-07-03 | Albright & Wilson Limited | Disinfectants |
CN101426539A (en) * | 2006-02-28 | 2009-05-06 | 贝克顿·迪金森公司 | Antimicrobial compositions and methods for locking catheters |
CN101720760A (en) * | 2008-10-17 | 2010-06-09 | 山东威高药业有限公司 | Multifunctional disinfectant for haemodialysis machine |
CN103766377A (en) * | 2012-10-26 | 2014-05-07 | 杭州元祺生物科技有限公司 | Citric acid decalcified disinfectant applied to dialysis machinery and water treatment and preparation method of citric acid decalcified disinfectant |
Also Published As
Publication number | Publication date |
---|---|
CN104126609A (en) | 2014-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6956143B2 (en) | Antimicrobial composition and how to use it | |
CN101189017B (en) | Method of using oxidative reductive potential water solution in dental applications | |
CN1084149C (en) | Quick acting chemical sterilant | |
Leers | Disinfecting endoscopes: how not to transmit Mycobacterium tuberculosis by bronchoscopy | |
BRPI0613285A2 (en) | mycobactericidal composition, method for disinfecting a surface and method for inactivating mycobacteria, bacteria, viruses or fungi | |
CN107109298B (en) | Cleaning composition | |
CN102639129A (en) | Antimicrobial compositions containing free fatty acids | |
CN101219223A (en) | Medical supersonic couplant with disinfection function and method for preparing the same | |
WO2012081673A1 (en) | Ophthalmic composition for contact lens | |
CN101163492A (en) | Method of treating skin ulcers using oxidative reductive potential water solution | |
Stawarz-Janeczek et al. | Disinfectants used in stomatology and SARS-CoV-2 infection | |
CN104126609B (en) | For cleaning colpomicroscopic thimerosal and preparation method thereof | |
CN108157358A (en) | A kind of thimerosal and preparation method thereof | |
JP2011502143A (en) | Bactericidal composition comprising peracid and acetylsalicylic acid | |
CN104206414B (en) | For cleaning thimerosal of red-light therapeutic instrument and preparation method thereof | |
RU2524621C1 (en) | Stabilised antimicrobial gel compound of hydrogen peroxide | |
KR102214477B1 (en) | Oral care method and oral care system | |
Scott et al. | The comparative value of metaphen in alcohol-acetone-aqueous solutions in the pre-operative disinfection of the skin | |
CN101862460B (en) | Sterilizing medicinal ultrasonic coupling agent and preparation method thereof | |
CN116784324A (en) | Foam disinfectant for invisible appliance, preparation method and application thereof | |
JPH11199476A (en) | Composition for disinfection and/or sterilization | |
CN120093622A (en) | Quaternary ammonium salt type antibacterial hand-washing-free disinfectant and preparation method thereof | |
CN119924314A (en) | A neutral peracetic acid disinfectant for endoscope disinfection | |
WO2023101653A1 (en) | Detergent compositions for cleaning in the cosmetic and pharmaceutical industry | |
CN104490650A (en) | Disinfectant and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Jin Haixia Inventor after: Chen Lei Inventor after: Yao Guidong Inventor after: Shi Senlin Inventor before: Zhang Guangrong |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160629 Address after: 450052 reproductive medicine center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 27, Henan, China Applicant after: Jin Haixia Address before: 250014, Shandong City, Ji'nan Province Ring mountain road, surrounded by mountains Applicant before: Zhang Guangrong |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20170820 |
|
CF01 | Termination of patent right due to non-payment of annual fee |